Paul Crowe

Paul Crowe has a vast experience in the pharmaceutical industry, starting from their early career as a postdoctoral fellow at the University of California, Riverside. Paul then transitioned to roles at Neurocrine Biosciences, Efficacy Consulting, and currently serves as the VP of Drug Discovery at Orphagen Pharmaceuticals. With a strong background in pharmacology and physiology, Paul has been instrumental in drug discovery and development for a wide range of diseases such as cancer, endocrine disorders, and autoimmune diseases. Paul's expertise in molecular pharmacology, target validation, and project management has been evident throughout their career.